These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22723940)

  • 21. Association of High-Density Lipoprotein-Cholesterol Versus Apolipoprotein A-I With Risk of Coronary Heart Disease: The European Prospective Investigation Into Cancer-Norfolk Prospective Population Study, the Atherosclerosis Risk in Communities Study, and the Women's Health Study.
    van Capelleveen JC; Bochem AE; Boekholdt SM; Mora S; Hoogeveen RC; Ballantyne CM; Ridker PM; Sun W; Barter PJ; Tall AR; Zwinderman AH; Kastelein JJP; Wareham NJ; Khaw KT; Hovingh GK
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28775061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I.
    Leren TP; Bakken KS; Daum U; Ose L; Berg K; Assmann G; von Eckardstein A
    J Lipid Res; 1997 Jan; 38(1):121-31. PubMed ID: 9034206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations among apolipoproteins, oxidized high-density lipoprotein and cardiovascular events in patients on hemodialysis.
    Honda H; Hirano T; Ueda M; Kojima S; Mashiba S; Hayase Y; Michihata T; Shishido K; Takahashi K; Hosaka N; Ikeda M; Sanada D; Shibata T
    PLoS One; 2017; 12(5):e0177980. PubMed ID: 28542510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
    Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of lipoprotein A-I and lipoprotein A-I/A-II in predicting coronary artery disease.
    O'Brien T; Nguyen TT; Hallaway BJ; Hodge D; Bailey K; Holmes D; Kottke BA
    Arterioscler Thromb Vasc Biol; 1995 Feb; 15(2):228-31. PubMed ID: 7749830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remodeling of HDL containing apoA-I but not apoA-II (LpA-I) by lipoprotein-deficient plasma and hepatic lipase: its effect on the structure and cellular cholesterol-reducing capacity of LpA-I.
    Ohta T; Ikeda Y; Hattori S; Matsuda I
    Biochim Biophys Acta; 1996 Sep; 1303(2):137-44. PubMed ID: 8856043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differences in HDL-cholesterol:apoA-I + apoA-II ratio and apoE phenotype with albuminuric status in Type I diabetic patients.
    Soedamah-Muthu SS; Colhoun HM; Taskinen MR; Idzior-Walus B; Fuller JH;
    Diabetologia; 2000 Nov; 43(11):1353-9. PubMed ID: 11126402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HDLs containing apolipoproteins A-I and A-II (LpA-I:A-II) as markers of coronary artery disease in men with non-insulin-dependent diabetes mellitus.
    Syvänne M; Kahri J; Virtanen KS; Taskinen MR
    Circulation; 1995 Aug; 92(3):364-70. PubMed ID: 7634450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution.
    Brinton EA; Eisenberg S; Breslow JL
    Arterioscler Thromb; 1994 May; 14(5):707-20. PubMed ID: 8172849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the lipid and apolipoprotein compositions of two species of apoA-I-containing lipoproteins in normolipidemic males and females.
    Ohta T; Hattori S; Nishiyama S; Matsuda I
    J Lipid Res; 1988 Jun; 29(6):721-8. PubMed ID: 3139812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein A-II: evaluating its significance in dyslipidaemia, insulin resistance, and atherosclerosis.
    Chan DC; Ng TW; Watts GF
    Ann Med; 2012 Jun; 44(4):313-24. PubMed ID: 21501035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma apolipoprotein concentrations in familial apolipoprotein A-I and A-II deficiency (Tangier disease).
    Alaupovic P; Schaefer EJ; McConathy WJ; Fesmire JD; Brewer HB
    Metabolism; 1981 Aug; 30(8):805-9. PubMed ID: 6790903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-density lipoprotein (HDL) transport in the metabolic syndrome: application of a new model for HDL particle kinetics.
    Ji J; Watts GF; Johnson AG; Chan DC; Ooi EM; Rye KA; Serone AP; Barrett PH
    J Clin Endocrinol Metab; 2006 Mar; 91(3):973-9. PubMed ID: 16368749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of human apolipoprotein A-II in apolipoprotein E-deficient mice induces features of familial combined hyperlipidemia.
    Escolà-Gil JC; Julve J; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
    J Lipid Res; 2000 Aug; 41(8):1328-38. PubMed ID: 10946021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects.
    Hughes TA; Stentz F; Gettys T; Smith SR
    Metabolism; 2006 Jan; 55(1):26-34. PubMed ID: 16324916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of apoA- and apoB-containing lipoprotein particles in a variant of familial apoA-I deficiency with planar xanthoma: the metabolic significance of LP-A-II particles.
    Bekaert ED; Alaupovic P; Knight-Gibson CS; Laux MJ; Pelachyk JM; Norum RA
    J Lipid Res; 1991 Oct; 32(10):1587-99. PubMed ID: 1797940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ApoA-IHelsinki (Lys107-->0) associated with reduced HDL cholesterol and LpA-I:A-II deficiency.
    Tilly-Kiesi M; Zhang Q; Ehnholm S; Kahri J; Lahdenperä S; Ehnholm C; Taskinen MR
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1294-306. PubMed ID: 7670941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-II.
    Rader DJ; Castro G; Zech LA; Fruchart JC; Brewer HB
    J Lipid Res; 1991 Nov; 32(11):1849-59. PubMed ID: 1770304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of macrophage-derived apolipoprotein E on plasma lipoprotein distribution of apolipoprotein A-I in apolipoprotein E-deficient mice.
    Spangenberg J; Curtiss LK
    Biochim Biophys Acta; 1997 Nov; 1349(2):109-21. PubMed ID: 9421184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
    Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
    J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.